Research progress on the relationship between adipokine Asprosin and diabetic kidney disease
10.3969/j.issn.1006-6187.2025.04.015
- VernacularTitle:脂肪因子白脂素与糖尿病肾脏疾病关系的研究进展
- Author:
Rongrong GAO
1
;
Gaohong LIU
Author Information
1. 030012 太原,山西医科大学第五临床医学院肾内科
- Publication Type:Journal Article
- Keywords:
Diabetic kidney disease;
Novel adipokine;
Asprosin;
Inflammatory response
- From:
Chinese Journal of Diabetes
2025;33(4):317-320
- CountryChina
- Language:Chinese
-
Abstract:
DKD is a common microvascular complication of diabetes mellitus and the main cause of chronic kidney disease in China.Asprosin is a novel adipokine,which plays an important regulatory role in IR,glucose and lipid metabolism,inflammatory response and mitochondrial function.Asprosin is closely related to diabetes mellitus,obesity and other diseases,and may be involved in the pathophysiological process of DKD.Asprosin is expected to become a new biomarker and potential therapeutic target for early screening and diagnosis of DKD.Therefore,this article reviews the research progress of Asprosin in DKD.
